Mepolizumab Antibody
Mepolizumab is a humanized monoclonal antibody that neutralizes interleukin-5 (IL-5) . It is a key research tool for investigating severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis (EGPA), supporting both in vitro mechanistic studies and in vivo preclinical models of eosinophil-driven diseases.
Product Specifications
Product Name Alternative
Activation, inhibit, polyangiitis, neutralizes interleukin-5, ILReceptor, IL-5, Mepolizumab, IL Receptor, Inhibitor, Interleukin Related, EGPA, eosinophil proliferation, eosinophilic asthma, eosinophilic granulomatosis, humanized monoclonal antibody, SB240563, SB-240563, SB 240563, survival
Target
Interleukin, IL Receptor
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
101.3 mg/mL
Purity
98.00% (May vary between batches)
Molecular Weight
146.24 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
